Denali Therapeutics
DNLI
#3994
Rank
NZ$4.98 B
Marketcap
NZ$34.02
Share price
-1.35%
Change (1 day)
-20.43%
Change (1 year)

Denali Therapeutics (DNLI) Fails to deliver data

Key failure to deliver metrics for Denali Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Denali Therapeutics (DNLI) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Denali Therapeutics (DNLI) - since 2017

Volume in USD (price x number of shares), data since 2017

Denali Therapeutics (DNLI) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025NZ$6.65 M628.72%
2024NZ$0.91 M-91.77%
2023NZ$11.08 M-27.7%
2022NZ$15.33 M-69.95%
2021NZ$51.03 M73.27%
2020NZ$29.45 M152.5%
2019NZ$11.66 M-71.68%
2018NZ$41.18 M381.24%
2017NZ$8.55 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Novocure
NVCR
NZ$0.2 MNZ$2.44 M Jersey
Novavax
NVAX
NZ$15.95 MNZ$65.06 M๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
NZ$1.48 MNZ$1.48 M๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
N/ANZ$0.31 M๐Ÿ‡ฌ๐Ÿ‡ง UK